151 related articles for article (PubMed ID: 27311760)
1. On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.
Risbrough VB; Glenn DE; Baker DG
Curr Top Behav Neurosci; 2016; 28():173-96. PubMed ID: 27311760
[TBL] [Abstract][Full Text] [Related]
2. Single prolonged stress: toward an animal model of posttraumatic stress disorder.
Yamamoto S; Morinobu S; Takei S; Fuchikami M; Matsuki A; Yamawaki S; Liberzon I
Depress Anxiety; 2009; 26(12):1110-7. PubMed ID: 19918929
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological intervention of conditioned fear and its extinction].
Huang R; Li Z; Chen H; Huang Y; Ding L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):968-72. PubMed ID: 23000774
[TBL] [Abstract][Full Text] [Related]
4. Fear extinction and memory reconsolidation as critical components in behavioral treatment for posttraumatic stress disorder and potential augmentation of these processes.
Smith NB; Doran JM; Sippel LM; Harpaz-Rotem I
Neurosci Lett; 2017 May; 649():170-175. PubMed ID: 28065842
[TBL] [Abstract][Full Text] [Related]
5. Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation.
Careaga MBL; Girardi CEN; Suchecki D
Neurosci Biobehav Rev; 2016 Dec; 71():48-57. PubMed ID: 27590828
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting corticosterone synthesis during fear memory formation exacerbates cued fear extinction memory deficits within the single prolonged stress model.
Keller SM; Schreiber WB; Stanfield BR; Knox D
Behav Brain Res; 2015; 287():182-6. PubMed ID: 25839906
[TBL] [Abstract][Full Text] [Related]
7. Postreactivation glucocorticoids impair recall of established fear memory.
Cai WH; Blundell J; Han J; Greene RW; Powell CM
J Neurosci; 2006 Sep; 26(37):9560-6. PubMed ID: 16971540
[TBL] [Abstract][Full Text] [Related]
8. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
[TBL] [Abstract][Full Text] [Related]
9. The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear.
Huang F; Yang Z; Li CQ
Vitam Horm; 2017; 103():281-294. PubMed ID: 28061973
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine facilitates between-session extinction and prevents reinstatement of auditory-cue conditioned fear.
Yang CH; Shi HS; Zhu WL; Wu P; Sun LL; Si JJ; Liu MM; Zhang Y; Suo L; Yang JL
Behav Brain Res; 2012 Apr; 230(1):268-73. PubMed ID: 22366271
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic glutamatergic manipulations on conditioned eyeblink responses and hyperarousal in a rabbit model of post-traumatic stress disorder.
Burhans LB; Smith-Bell CA; Schreurs BG
Behav Pharmacol; 2017 Oct; 28(7):565-577. PubMed ID: 28799954
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
Singewald N; Schmuckermair C; Whittle N; Holmes A; Ressler KJ
Pharmacol Ther; 2015 May; 149():150-90. PubMed ID: 25550231
[TBL] [Abstract][Full Text] [Related]
13. Effects of Cortisol on Reconsolidation of Reactivated Fear Memories.
Drexler SM; Merz CJ; Hamacher-Dang TC; Tegenthoff M; Wolf OT
Neuropsychopharmacology; 2015 Dec; 40(13):3036-43. PubMed ID: 26058664
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues.
Baker KD; McNally GP; Richardson R
Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and central correlates of contextual fear learning and contextual modulation of cued fear in posttraumatic stress disorder.
Steiger F; Nees F; Wicking M; Lang S; Flor H
Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):584-93. PubMed ID: 26149734
[TBL] [Abstract][Full Text] [Related]
16. D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.
Ledgerwood L; Richardson R; Cranney J
Behav Neurosci; 2004 Jun; 118(3):505-13. PubMed ID: 15174928
[TBL] [Abstract][Full Text] [Related]
17. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
[TBL] [Abstract][Full Text] [Related]
18. cis-3-Hexenol and trans-2-hexenal mixture prevents development of PTSD-like phenotype in rats.
Nikaido Y; Yamada J; Migita K; Shiba Y; Furukawa T; Nakashima T; Ueno S
Behav Brain Res; 2016 Jan; 297():251-8. PubMed ID: 26475511
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.
Kuriyama K; Honma M; Yoshiike T; Kim Y
Neuropharmacology; 2013 Jan; 64():424-31. PubMed ID: 22992332
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced enhancement of fear conditioning and sensitization facilitates extinction-resistant and habituation-resistant fear behaviors in a novel animal model of posttraumatic stress disorder.
Corley MJ; Caruso MJ; Takahashi LK
Physiol Behav; 2012 Jan; 105(2):408-16. PubMed ID: 21925525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
